Literature DB >> 21847687

Role of the hospital pharmacy and therapeutics committee in detecting and regulating off-label drug use.

Jaime E Vargas-Rivas, Daniel Sabater-Hernández, Miguel A Calleja-Hernández, María J Faus, Fernando Martínez-Martínez.   

Abstract

Mesh:

Year:  2011        PMID: 21847687     DOI: 10.1007/s11096-011-9532-z

Source DB:  PubMed          Journal:  Int J Clin Pharm


× No keyword cloud information.
  6 in total

1.  Study of compliance with prescription information sheet of trastuzumab prescriptions in a tertiary level hospital.

Authors:  J E Vargas-Rivas; M M Montes-Casas; B Cancela-Diez; F Martínez-Martínez; D Sabater-Hernández; M A Calleja-Hernández
Journal:  Farm Hosp       Date:  2011-12-03

2.  Frontline therapy with rituximab added to the combination of cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) significantly improves the outcome for patients with advanced-stage follicular lymphoma compared with therapy with CHOP alone: results of a prospective randomized study of the German Low-Grade Lymphoma Study Group.

Authors:  Wolfgang Hiddemann; Michael Kneba; Martin Dreyling; Norbert Schmitz; Eva Lengfelder; Rudolf Schmits; Marcel Reiser; Bernd Metzner; Harriet Harder; Susanna Hegewisch-Becker; Thomas Fischer; Martin Kropff; Hans-Edgar Reis; Mathias Freund; Bernhard Wörmann; Roland Fuchs; Manfred Planker; Jörg Schimke; Hartmut Eimermacher; Lorenz Trümper; Ali Aldaoud; Reza Parwaresch; Michael Unterhalt
Journal:  Blood       Date:  2005-08-25       Impact factor: 22.113

Review 3.  Literature review on the structure and operation of Pharmacy and Therapeutics Committees.

Authors:  Esther Durán-García; Bernardo Santos-Ramos; Francesc Puigventos-Latorre; Ana Ortega
Journal:  Int J Clin Pharm       Date:  2011-03-18

4.  Off-label prescribing among office-based physicians.

Authors:  David C Radley; Stan N Finkelstein; Randall S Stafford
Journal:  Arch Intern Med       Date:  2006-05-08

5.  [Study of rituximab efficacy, cost, safety, and compliance of its package leaflet in a tertiary hospital].

Authors:  M C Conde García; M A Fernández Feijoo; M A Calleja Hernández
Journal:  Farm Hosp       Date:  2009 Nov-Dec

6.  New treatments for advanced cancer: an approach to prioritization.

Authors:  J S Ferguson; M Summerhayes; S Masters; S Schey; I E Smith
Journal:  Br J Cancer       Date:  2000-11       Impact factor: 7.640

  6 in total
  1 in total

Review 1.  Off-label use of anti-cancer drugs between clinical practice and research: the Italian experience.

Authors:  Rosa Lerose; Pellegrino Musto; Michele Aieta; Carla Papa; Alfredo Tartarone
Journal:  Eur J Clin Pharmacol       Date:  2011-12-14       Impact factor: 2.953

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.